These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3109142

  • 1. [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
    Figulla HR, Luig H, Nieschlag F, Kreuzer H.
    Z Kardiol; 1987 Mar; 76(3):167-74. PubMed ID: 3109142
    [Abstract] [Full Text] [Related]

  • 2. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 3. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF, Grom E, Jähnchen E, Roskamm H.
    J Cardiovasc Pharmacol; 1989 Feb; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [Abstract] [Full Text] [Related]

  • 4. [Hemodynamic and clinical effects of captopril in congestive heart failure].
    Galiè N, Magelli C, Ribani MA, Bassein L, Sanguinetti M, Magnani B.
    G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM, Kramer BL, Topic N.
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function].
    Osterziel KJ, Dietz R, Mikulaschek K, Röhrig N, Schmid W, Manthey J, Kübler W.
    Z Kardiol; 1988 Jun; 77(6):378-84. PubMed ID: 2850682
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
    Aschenberg W, Nienaber C, Spielmann R, Bleifeld W.
    Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
    Vogt A, Kreuzer H.
    Arzneimittelforschung; 1983 Apr; 33(6):877-9. PubMed ID: 6684444
    [Abstract] [Full Text] [Related]

  • 10. [Mechano- and impedance cardiography parameters in patients with heart failure in administration of a calcium antagonist. The significance of the Heather index].
    Linde M, Ohnhaus EE, Kirch W.
    Z Kardiol; 1989 Mar; 78(3):181-6. PubMed ID: 2652906
    [Abstract] [Full Text] [Related]

  • 11. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure].
    Tsuda T, Izumi T, Kodama M, Hanawa H, Ohshima M, Takahashi M, Suzuki M, Aizaki T, Uchiyama H, Shibata A.
    J Cardiol; 1992 Mar; 22(4):721-9. PubMed ID: 1343639
    [Abstract] [Full Text] [Related]

  • 12. Comparison of captopril and enalapril in patients with severe chronic heart failure.
    Packer M, Lee WH, Yushak M, Medina N.
    N Engl J Med; 1986 Oct 02; 315(14):847-53. PubMed ID: 3018566
    [Abstract] [Full Text] [Related]

  • 13. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A, Escudier B, Hannachi N, Kolski H, Witchitz S, Acar J.
    Arch Mal Coeur Vaiss; 1984 Jan 02; 77(1):92-9. PubMed ID: 6422898
    [Abstract] [Full Text] [Related]

  • 14. [Captopril therapy in chronic congestive heart failure].
    Morgera T, Humar F, Mestroni L, Maras P, Camerini F.
    G Ital Cardiol; 1983 Jan 02; 13(1):39-46. PubMed ID: 6347789
    [Abstract] [Full Text] [Related]

  • 15. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC, Chakraborty S, Mondal M, Bhandari B.
    J Assoc Physicians India; 1993 May 02; 41(5):269-71. PubMed ID: 8300456
    [Abstract] [Full Text] [Related]

  • 16. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N, Schmidt-Moritz AD, Nadj M, Kaltenbach M, Bussmann WD.
    Z Kardiol; 1985 Apr 02; 74(4):205-12. PubMed ID: 3923726
    [Abstract] [Full Text] [Related]

  • 17. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
    Ourbak P, Pornin M, Melanidis J, Bouziri S, Allal J, Sellier P, Maurice P.
    Arch Mal Coeur Vaiss; 1984 Aug 02; 77(8):865-71. PubMed ID: 6435565
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U, Blasini R, Rudolph W.
    Herz; 1984 Aug 02; 9(4):244-52. PubMed ID: 6434387
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic and clinical effects of captopril in patients with severe congestive heart failure.
    Nigri A, Mangieri E, Martuscelli E, Danesi A, Sardella G, Berni A, Sardella F.
    Cardiologia; 1989 Jun 02; 34(6):525-9. PubMed ID: 2676169
    [Abstract] [Full Text] [Related]

  • 20. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE.
    Arterioscler Thromb Vasc Biol; 2004 Jun 02; 24(6):1043-8. PubMed ID: 15105283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.